Peroxisome proliferator-activated receptor (PPARs) in the vessel wall - New regulators of gene expression in vascular cells;Peroxisome proliferator-activated receptors (PPARs) in der gefäßwand - Neue regulatoren der genexpression in vaskulären zellen

Zeitschrift fur Kardiologie

Volumn 90, Issue 7, 2001, Pages 470-477

  Marx, N ^a   Hombach, V ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Atherogenesis; Gene expression; Inflammation; PPARs; Vascular cells

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; FIBRIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BLOOD VESSEL WALL; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; LIGAND BINDING; LIPID METABOLISM; LIPOGENESIS; REVIEW; VASCULAR DISEASE;

ANIMALS; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; CHROMANS; CLINICAL TRIALS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GEMFIBROZIL; GENE EXPRESSION REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; LIGANDS; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; PEROXISOME PROLIFERATORS; PROCETOFEN; RATS; RESEARCH; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 18244420050     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920170135     Document Type: Review

References (52)

1. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: No alteration in adipose tissue of obese and NIDDM patients
2. Rosiglitazone
3. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
4. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1
5. Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner
6. Peroxisome proliferator-activated receptor activators inhibit thrombin- induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway
7. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome
8. The organization, promoter analysis, and expression of the human PPARgamma gene
9. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
10. PPARgamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells
11. TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent
12. Progression and regression of minor coronary arterial narrowings by quantitative angiography after fenofibrate therapy
13. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
14. Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
15. Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells
16. PPARgamma agonists inhibit production of monocyte inflammatory cytokines
17. Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function
18. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
19. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
20. The inverse relation between fish consumption and 20-year mortality from coronary heart disease
21. PPARgamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
22. Expression and function of PPARgamma in rat and human vascular smooth muscle cells
23. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
24. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells
25. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARgamma)
26. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
27. Molecular bases of the acute coronary syndromes
28. The adipocyte and hemostatic balance in obesity: Studies of PAI-1
29. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease
30. PPARγ activators inhibit Interferon-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells
31. PPARalpha activators inhibit tissue factor expression and activity in human monocytes
32. Peroxisome proliferator activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells
33. PPARα activators inhibit cytokine-induced vascular cell adhesion molecule 1 expression in human endothelial cells
34. Macrophages in human atheroma contain PPARgamma: Differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro
35. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes
36. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
37. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators
38. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
39. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
40. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
41. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
42. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: A new possible role of PPARgamma on vascular endothelial function
43. Thiazoledinediones: An update
44. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
45. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation
46. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
47. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
48. Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study (DAIS)
49. Peroxisome proliferator-activated receptor activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells
50. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
51. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
52. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo